Paraproteinemia-associated scleredema treated successfully with intravenous immunoglobulin

JAMA Dermatol. 2014 Jul;150(7):788-9. doi: 10.1001/jamadermatol.2013.8835.

Authors

A Brooke Eastham¹, Alisa N Femia², Nicole F Velez¹, Hedy P Smith³, Ruth Ann Vleugels²

Affiliations

¹ Harvard Combined Dermatology Residency Program, Boston, Massachusetts2Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts3Harvard Medical School, Boston, Massachusetts.
² Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts3Harvard Medical School, Boston, Massachusetts.
³ Division of Hematology, Department of Medicine, Tufts Medical School, Boston, Massachusetts.

PMID: 24847975
DOI: 10.1001/jamadermatol.2013.8835

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Female
Humans
Immunoglobulins, Intravenous / therapeutic use*
Immunologic Factors / therapeutic use*
Middle Aged
Paraproteinemias / complications
Paraproteinemias / drug therapy*
Range of Motion, Articular
Scleredema Adultorum / complications
Scleredema Adultorum / drug therapy*

Substances

Immunoglobulins, Intravenous
Immunologic Factors